Infection Rates of Hepatitis B and C in Injecting Drug Users
Author Information
Author(s): Andrew Sutton, Nigel Gay, William Edmunds, Vivian Hope, Noel Gill, Matthew Hickman
Primary Institution: Centre for Research on Drugs and Health Behaviour, Imperial College London
Hypothesis
What is the force of infection for hepatitis B and C in injecting drug users in England and Wales?
Conclusion
The study emphasizes the need for targeted interventions for new injecting drug users to reduce the transmission of hepatitis B and C.
Supporting Evidence
- Injecting drug users are at greatest risk of infection in their first year of injecting.
- The force of infection for hepatitis C is higher than for hepatitis B among new initiates.
- There is evidence of individual heterogeneity in risk behavior among injecting drug users.
Takeaway
New drug users are much more likely to get hepatitis B and C infections than those who have been using drugs for a longer time.
Methodology
The study analyzed data from voluntary unlinked anonymous surveys of injecting drug users, focusing on those tested for hepatitis B and C from 1998 to 2003.
Potential Biases
Potential bias exists if the surveyed injecting drug users differ significantly from the overall population in terms of infection rates.
Limitations
The sample may not be representative of all injecting drug users, as participants were self-selected and in contact with specialist agencies.
Participant Demographics
Participants were injecting drug users aged 16-49 years, with a focus on those unvaccinated against hepatitis B.
Statistical Information
P-Value
0.1076 for HBV, 0.1608 for HCV
Confidence Interval
HBV: 0.0840–0.1327; HCV: 0.1314–0.1942
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website